201 related articles for article (PubMed ID: 18472978)
1. Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results.
Metra M; Nodari S; Bordonali T; Milani P; Lombardi C; Bugatti S; Fontanella B; Verzura G; Danesi R; Dei Cas L
Ther Clin Risk Manag; 2007 Aug; 3(4):569-78. PubMed ID: 18472978
[TBL] [Abstract][Full Text] [Related]
2. Bisoprolol and heart failure: new frontiers.
Chopra HK
Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027
[TBL] [Abstract][Full Text] [Related]
3. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
4. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
Domanski MJ; Krause-Steinrauf H; Massie BM; Deedwania P; Follmann D; Kovar D; Murray D; Oren R; Rosenberg Y; Young J; Zile M; Eichhorn E;
J Card Fail; 2003 Oct; 9(5):354-63. PubMed ID: 14583895
[TBL] [Abstract][Full Text] [Related]
6. Bisoprolol: a review of its use in chronic heart failure.
McGavin JK; Keating GM
Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
[TBL] [Abstract][Full Text] [Related]
7. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
[TBL] [Abstract][Full Text] [Related]
8. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
9. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.
Erdmann E; Lechat P; Verkenne P; Wiemann H
Eur J Heart Fail; 2001 Aug; 3(4):469-79. PubMed ID: 11511434
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers in heart failure. The 'new wave' of clinical trials.
Krum H
Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
[TBL] [Abstract][Full Text] [Related]
11. Use of beta-blockers in congestive heart failure.
Sallach JA; Goldstein S
Ann Med; 2003; 35(4):259-66. PubMed ID: 12846268
[TBL] [Abstract][Full Text] [Related]
12. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
[TBL] [Abstract][Full Text] [Related]
13. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
[TBL] [Abstract][Full Text] [Related]
14. Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
Wikstrand J; Ghali JK; Goldstein S
Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):16-23. PubMed ID: 19667604
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
[TBL] [Abstract][Full Text] [Related]
16. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
Ellison KE; Gandhi G
Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
[TBL] [Abstract][Full Text] [Related]
17. [Beta blockers in therapy of chronic heart failure].
Hoffman J; Grimm W; Maisch B
Herz; 2002 Mar; 27(2):150-65. PubMed ID: 12025460
[TBL] [Abstract][Full Text] [Related]
18. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
[TBL] [Abstract][Full Text] [Related]
19. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
[TBL] [Abstract][Full Text] [Related]
20. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
